GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment. Mission GSK's mission is to improve the quality of human life by enabling people to do more, feel better and live longer. Strategic Intent GSK's strategic intent is to be the indisputable leader in the industry. Spirit of GSK Our company spirit describes how we need to behave if we are to achieve our goal. "We undertake our quest with the enthusiasm of entrepreneurs, excited by the constant search for innovation. We value performance achieved with integrity. We will attain success as a world class leader with each and every one of our people contributing with passion and an unmatched sense of urgency." Headquartered in the UK and with operations based in the US, the company is one of the industry leaders, with 6.3% per cent of the world's pharmaceutical market. GSK has a leadership position in anti-infectives, respiratory and vaccines and has a growing portfolio of oncology products. The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders. Highlights of GlaxoSmithKline (Pakistan) Ltd Overview GlaxoSmithKline Pakistan Ltd was formed in 2002 as a result of the global merger of two pharmaceutical giants; GlaxoWellcome plc and SmithKline Beecham plc GSK is the largest pharmaceutical company in Pakistan with a growing export business to Afghanistan. Sales in 2005 amounted to US$157 million. GlaxoSmithKline Pakistan is headquartered in Karachi and employees 1800 people. GlaxoSmithKline believes that continued investment in research into diseases that affect the developing world is essential if there is to be a long term improvement in the healthcare of people living in the region; this will include the resolution of challenged such as drug resistance and poor patient compliance. The work under taken focuses on malaria, tuberculosis, HIV AIDS and vaccines allowing GlaxoSmithKline to address the prevention and treatment of all three of the World Health Organizations top priority diseases. Product Portfolio GSK's primary activities are the manufacture, import of and marketing of research based pharmaceutical and consumer healthcare products. Principal therapeutic areas include Antibiotics, Respiratory, Dermatological Gastro-intestinal & Metabolic, Analgesics, Central Nervous System and Vaccines. Every year, in Pakistan as elsewhere in the developing world, countless infants as well as adults die from diseases that could easily be prevented by vaccines. As one of the worlds largest vaccine producers, GSK is committed to saving these precious lives by delivering vaccines against the major killer diseases such as Hepatitis B, Typhoid and Rotavirus, GSK is also the preferred partner of infant Immunization Programs world wide supported by GAVI, WHO and Pan American Health Organization. The introduction of Seretide (Salmeterol / fluticasone propionate) a novel treatment for effective asthma control is expected to improve the lives of asthma sufferers. GSK is committed to improving peoples lives by delivering products that enables them to do more, feel better and live longer. Segment Leadership in the Pakistani Pharma Market # 1 Company # 1 product by value # 1 product by Rx. # 1 rating from customer # 1 in Antibiotics / Respiratory / Vaccines / Analgesics / Derma / Anti-Malarial / anti Virals / Anti-hemantics / Anti Ulcerants